Articles tagged with Cancer Patients
Scientists at NIH developed a new drug that reduces tumor size without severe side effects. In a clinical trial, 9 of 15 patients had significant tumor regression, with complete disappearance in two cases. A related therapy using virus-producing cells also showed promise, but only for small tumors.
A US research team, led by Dr. Barton Kamen, has made significant progress in treating stubborn cancers with aminopterin, a drug that was previously shelved due to toxicity concerns. The FDA has granted $447,534 for further studies on the drug, which shows promise in treating patients with leukemia and other cancers.
A study by CWRU sociologists found that adults who identify as survivors earlier in their cancer journey tend to have better mental health outcomes. Adopting a survivor mindset can help individuals adopt an active role in the healing process and reduce distress.
A new study of over 1,000 prostate cancer patients found that those who underwent surgery had remarkably good outcomes, with few reporting dissatisfaction or problems with urinary or sexual function. Despite fears about complications, most men felt healthier and satisfied with their treatment after surgery.
Researchers at University at Buffalo and Roswell Park Cancer Institute found no link between chemotherapy use and cancer risk in children's offspring. The study analyzed health records of 153 children born to 91 chemotherapy patients, showing none developed cancer.
Researchers at Brown University have developed a drug and radiation regimen that demonstrates substantial activity in reducing locally advanced and inoperable tumors in the pancreas and stomach.
Hospice care is underused in the US, with most patients enrolling too late to benefit from it. Short stays can lessen the effectiveness of hospice care, leaving little time for caregivers to learn about the patient's needs and arrange optimal care.
A new clinical trial has shown that combining chemotherapy with radiation therapy can improve the survival rate of patients with nasopharyngeal carcinoma by 31% compared to radiation alone. The treatment, which included cisplatin and 5-fluorouracil, resulted in a three-year survival rate of 76% for those receiving the combination therapy.
A new drug, CPT-11, has been approved by the FDA for treating colorectal cancer. Researchers plan to enroll approximately 660 patients in a Phase III trial to evaluate its effectiveness as a first-line treatment.